| SC 13G/A | 2019-02-14 | Opaleye Management Inc. | HARROW HEALTH, INC. | 9 | 11.0% | EDGAR |
| SC 13D | 2018-11-23 | Imprimis Pharmaceuticals, Inc. | Eton Pharmaceuticals, Inc. | 3,500,000 | 20.7% | EDGAR |
| SC 13G | 2018-09-07 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | 9 | 11.0% | EDGAR |
| SC 13G/A | 2017-04-19 | Longboard Capital Advisors, LLC | Imprimis Pharmaceuticals, Inc. | 1,416,000 | 7.1% | EDGAR |
| SC 13G | 2017-03-29 | Longboard Capital Advisors, LLC | Imprimis Pharmaceuticals, Inc. | 1,312,000 | 6.6% | EDGAR |
| SC 13G/A | 2017-02-23 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2017-02-17 | Perella Weinberg Partners Capital Management LP | Imprimis Pharmaceuticals, Inc. | 125,000 | 0.9% | EDGAR |
| SC 13G/A | 2017-02-14 | MARATHON ASSET MANAGEMENT LP | Imprimis Pharmaceuticals, Inc. | 833,333 | 4.5% | EDGAR |
| SC 13D/A | 2016-08-30 | Kammer Robert J | Imprimis Pharmaceuticals, Inc. | 975,058 | 7.4% | EDGAR |
| SC 13G | 2016-03-28 | Perella Weinberg Partners Capital Management LP | Imprimis Pharmaceuticals, Inc. | 958,333 | 6.8% | EDGAR |
| SC 13G | 2016-03-21 | MARATHON ASSET MANAGEMENT LP | Imprimis Pharmaceuticals, Inc. | 833,333 | 6.4% | EDGAR |
| SC 13G/A | 2016-02-16 | MANCHESTER MANAGEMENT CO LLC | Imprimis Pharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-12 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2016-02-12 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13D/A | 2015-12-28 | Kammer Robert J | Imprimis Pharmaceuticals, Inc. | 975,058 | 10.1% | EDGAR |
| SC 13G/A | 2015-05-20 | Miloni Donald Paul | Imprimis Pharmaceuticals, Inc. | 747,055 | 7.8% | EDGAR |
| SC 13G/A | 2015-05-20 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2015-02-13 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | - | - | EDGAR |
| SC 13G/A | 2015-01-22 | MANCHESTER MANAGEMENT CO LLC | Imprimis Pharmaceuticals, Inc. | 578,360 | 6.2% | EDGAR |
| SC 13G | 2014-09-05 | Opaleye Management Inc. | Imprimis Pharmaceuticals, Inc. | - | - | EDGAR |